FENC R&D Expense Growth
Fennec Pharmaceuticals Inc · R&D Expense Growth
FENC R&D Expense Growth
Latest reported-18.57%period ending
FENC FY R&D Growth (YoY) (0.00% → -18.57%)
Latest values, visible window
High-resolution chart · PNG
FENC r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -18.5668% | |
| 448.2143% | |
| -98.414% | |
| -29.1106% | |
| -2.429% | |
| -11.0217% | |
| 14.5638% | |
| 158.6777% | |
| 310.1695% | |
| 84.375% | |
| -28.2913% | |
| -40.201% | |
| -71.2289% | |
| 38.8889% | |
| 111.0169% | |
| -66.4931% | |
| -79.6161% | |
| -5.0037% | |
| -22.0738% | |
| 12.5553% | |
| 246.7529% | |
| 1.1887% | |
| 13.1527% | |
| 64.0514% | |
| 0% | |
| 0% |